drugset / Trial / NCT06883123

Efficacy of Simbrinza and Rocklatan vs Cosopt and Latanoprost

NCT06883123

Phase 4 Recruiting 70 enrolled Prairie Eye Center Sengi · collab
RandomizedParallel-groupQuadruple-blindBasic science

Summary

A randomized, multi-site, parallel-group, prospective study of patients who are adults with a diagnosis of mild to moderate open-angle glaucoma (OAG), currently on an on-label use of combination topical medication of Cosopt and Latanoprost for a minimum of 1 month.

Timeline

Start
2025-05-14
Primary completion
2026-04-01
Completion
2026-04-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Brimonidine Small molecule 0.2 % Topical
Subject Brinzolamide Small molecule 1 % Topical
Comparator Dorzolamide Small molecule 2 % Topical
Comparator Latanoprost Small molecule 0.005 % Topical
Subject Netarsudil Small molecule 0.02 % Topical
Comparator Timolol Other / unclassified 0.5 % Topical

Indications